Megsan Pharmaceuticals Private Limited
About Megsan Pharmaceuticals Private Limited
Data last updated:
Megsan Pharmaceuticals Private Limited is a private limited company based in Cuttack, Odisha, India. It operates in the wholesale distribution segment of the trading and commerce sector. It was incorporated on 07 June 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Cuttack, under CIN U24230OR2012PTC015490.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Manish Shrivastava and Bharati Shrivastava.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Dagarpada Gopal Sahi Post Chandani Chowk, Cuttack, Odisha, India – 753002.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.89 Lakh, a decline of 35% compared to the previous year. For the same year it recorded a net profit of ₹3,959 (net margin 2.1%) and EBITDA of ₹5,349 (EBITDA margin 2.8%). Revenue has declined at a compounded annual rate (CAGR) of 10% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Megsan Pharmaceuticals Private Limited's registered office is in Cuttack, Odisha. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressDagarpada Gopal Sahi Post Chandani Chowk, Cuttack, Odisha, India – 753002
- IndustryTrading, Other Wholesale, Wholesale
To see the full contact details of Megsan Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Megsan Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Megsan Pharmaceuticals Private Limited, buy the company report.
Financials of Megsan Pharmaceuticals Private Limited
FY 2025 filings availableMegsan Pharmaceuticals Private Limited reported revenue of ₹1.89 Lakh (down 35% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 10% over five years, including a 35% fall in the latest year. EBITDA rose 1% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹5,349 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹3,959 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.8% | ||||
| Net Profit Margin | 2.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Megsan Pharmaceuticals Private Limited, buy the company report.
Board of directors of Megsan Pharmaceuticals Private Limited
Megsan Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Manish Shrivastava | Director | 07 Jun 2012 | 14 Years 4 Months | Current |
| Bharati Shrivastava | Director | 07 Jun 2012 | 14 Years 4 Months | Current |
Peer comparison
Megsan Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Neophyte Pharmaceuticals Private Limited | ₹1.91 Lakh (FY 2024) | -72.0% | Patna, Bihar, India | |||
| Vindhyachal Pharmaceuticals Private Limited | ₹1.89 Lakh (FY 2019) | -94.0% | Umarkhed, Maharashtra, India | |||
| Megsan Pharmaceuticals Private Limitedthis company | ₹1.89 Lakh (FY 2025) | ₹3,959 | 2.1% | -35.0% | Cuttack, Odisha, India | |
| Experon Pharmaceuticals Private Limited | ₹1.88 Lakh (FY 2025) | -51.0% | Gorakhpur, Uttar Pradesh, India | |||
| Hindraj Pharmaceuticals Private Limited | ₹1.88 Lakh (FY 2023) | 795.0% | Delhi, India | |||
| Sofitt Pharmaceuticals Private Limited | ₹1.87 Lakh (FY 2020) | Pataudi, Haryana, India |
To see the full peer comparison of Megsan Pharmaceuticals Private Limited, buy the company report.
Auditor
Megsan Pharmaceuticals Private Limited is audited by PRAMOD BOTHRA for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| PRAMOD BOTHRA | FY 2017 | 079409 |
Shareholding
The shareholding of Megsan Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Megsan Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Megsan Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Megsan Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Megsan Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Megsan Pharmaceuticals Private Limited has 2 board changes on record since 2012: 2 appointments. The latest: Bharati Shrivastava was appointed as Director on 07 Jun 2012.
Frequently asked questions
Megsan Pharmaceuticals is an active private limited company based in Cuttack, Odisha, India. The company works in other wholesale, within the trading industry. It was incorporated on 07 June 2012 (14+ years old) and is registered under CIN U24230OR2012PTC015490.
Megsan Pharmaceuticals has 2 current directors:
- Manish Shrivastava - Director
- Bharati Shrivastava - Director
The latest financial statements of Megsan Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Megsan Pharmaceuticals is U24230OR2012PTC015490. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Megsan Pharmaceuticals was incorporated on 07 June 2012, making it 14+ years old. It is registered with the Registrar of Companies, Cuttack.
The peers of Megsan Pharmaceuticals by revenue are Neophyte Pharmaceuticals Private Limited, Vindhyachal Pharmaceuticals Private Limited, Experon Pharmaceuticals Private Limited, Hindraj Pharmaceuticals Private Limited, Sofitt Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Bharati Shrivastava was appointed as Director on 07 Jun 2012. Manish Shrivastava was appointed as Director on 07 Jun 2012.
The registered office of Megsan Pharmaceuticals is at Dagarpada Gopal Sahi Post Chandani Chowk, Cuttack, Odisha, India – 753002.
Megsan Pharmaceuticals operates in the trading industry, in the other wholesale segment.
The compliance status of Megsan Pharmaceuticals is compliant as of 17 July 2026. The company is actively filing with the Registrar of Companies.
Megsan Pharmaceuticals can be reached at its registered office: Dagarpada Gopal Sahi Post Chandani Chowk, Cuttack, Odisha, India – 753002.